Label: METOPROLOL TARTRATE- metoprolol tartrate tablet, film coated
METOPROLOL TARTRATE tablet, film coated
- NDC Code(s): 71335-0689-1, 71335-0689-2, 71335-0689-3, 71335-0689-4, view more
- Packager: Bryant Ranch Prepack
- This is a repackaged label.
- Source NDC Code(s): 42543-001, 42543-002, 42543-003
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated June 11, 2019
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
DESCRIPTIONMetoprolol tartrate is a selective beta1-adrenoreceptor blocking agent, available as 25 mg, 50 mg, and 100 mg tablets for oral administration. Metoprolol tartrate is ...
-
CLINICAL PHARMACOLOGYMechanism of Action - Metoprolol is a beta1-selective (cardioselective) adrenergic receptor blocker. This preferential effect is not absolute, however, and at higher plasma concentrations ...
-
Special Populations Geriatric Patients - The geriatric population may show slightly higher plasma concentrations of metoprolol as a combined result of a decreased metabolism of the drug in elderly population and a ...
-
Clinical StudiesHypertension - In controlled clinical studies, metoprolol has been shown to be an effective antihypertensive agent when used alone or as concomitant therapy with thiazide-type diuretics, at ...
-
INDICATIONS AND USAGEHypertension - Metoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Angina ...
-
CONTRAINDICATIONSHypertension and Angina - Metoprolol tartrate tablets are contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see ...
-
WARNINGSHeart Failure - Beta-blockers, like metoprolol, can cause depression of myocardial contractility and may precipitate heart failure and cardiogenic shock. If signs or symptoms of heart failure ...
-
Drug InteractionsCatecholamine-Depleting Drugs - Catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents or monoamine oxidase (MAO) inhibitors. Observe ...
-
ADVERSE REACTIONSHypertension and Angina - Most adverse effects have been mild and transient. Central Nervous System - Tiredness and dizziness have occurred in about 10 of 100 patients. Depression has been ...
-
OVERDOSAGEAcute Toxicity - Several cases of overdosage have been reported, some leading to death. Oral LD - 50's (mg/kg): mice, 1,158 to 2,460; rats, 3,090 to 4,670 ...
-
DOSAGE AND ADMINISTRATIONHypertension - Individualize the dosage of metoprolol tartrate tablets. Metoprolol tartrate tablets should be taken with or immediately following meals. The usual initial dosage of metoprolol ...
-
HOW SUPPLIEDProduct: 71335-0689 - NDC: 71335-0689-1 30 TABLET, FILM COATED in a BOTTLE - NDC: 71335-0689-2 100 TABLET, FILM COATED in a BOTTLE - NDC: 71335-0689-3 60 TABLET, FILM COATED in a ...
-
Metoprolol Tartrate 100mg Tablet
-
Metoprolol tartrate 50mg Tablet
-
Metoprolol tartrate 25mg Tablet
-
INGREDIENTS AND APPEARANCEProduct Information